Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India ○
found
a story from CNBC ⚠️ › World News
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › April › 10
Ozempic
81 days ago
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
page 1 of 1